Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol ; volume:23 ; number:1 ; day:29 ; month:10 ; year:2021 ; pages:1-11 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (29.10.2021), 1-11, 12.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02650-4
- URN
-
urn:nbn:de:101:1-2022010821360998505282
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maksymowych, Walter P.
- Kumke, Thomas
- Auteri, Simone E.
- Hoepken, Bengt
- Bauer, Lars
- Rudwaleit, Martin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
P190: Cardiovascular Disease in Axial Spondyloarthritis